Endoscopic Doppler Ultrasound Probe: Useful in the Management of Gastric Varices?

Singh, Virendra; Kumar, Pramod

doi:10.1007/s10620-017-4747-z

Cited by 2 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Total 153 patients were enrolled for study. The inclusion criteria were as follows: (1) Age from 18 to 75 years old cirrhotic patients without any treatemt history for portal hypertension, including oral non-selective beta blockers, interventional radiology (such as TIPS), or surgical therapy (splenectomy and devascularization); (2) Esophageal varices were caused by liver cirrhosis with portal hypertension, (3) Esophageal varices were diagnosed by endosopy according to the guidelines [10], (4) The esophageal varices were individually treated by EVL, EIS, or EVL plus EIS. The following exclusion criteria were used in this study: (1) Endoscopic treatment failed to achieve eradication of esophageal varices, (2) TIPS, surgery or death were identified during the 3-year follow-up period, (3) Gastric varices (type GOV2, GOV3) or isolated gastric varices (IGV), (4) Child-Pugh score more than 14, (5) The function failures in the renal, brain, and heart, (6) Esophageal varices caused by no-cirrhotic portal hypertension.…”

Section: Methodsmentioning

confidence: 99%

“…However, these previous studies had small samples, short follow-up period (ranging from 1 to 3 months) and EUS was frequently performed before endoscopic therapies. Currently, the endoscopic ultrasound probe examinations (EUP) is easy and safe to operate compared with EUS performing [10, 11]. However, It was less knowledge that the EUP findings were as same usefulness as EUS in prediction variceal recurrence following endoscopic therapies.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study

Zheng

Zhang

et al. 2019

BMC Gastroenterol

View full text Add to dashboard Cite

Background The recurrence of esophageal varices remains high in patients with hepatic portal hypertension after the endoscopic esophageal variceal eradication therapies, including endoscopic variceal band ligation (EVL), injection sclerotherapy (EIS) or EVL plus EIS. The aim of this study was to evaluate the endoscopic ultrasound probe examinations (EUP) findings in the prediction of recurrence following esophageal variceal eradication in a prospective cohort. Methods A total of 206 cirrhotic portal hypertension patients with esophageal variceal eradication, who underwent endoscopic variceal therapy (EVL or EIS or EVL plus EIS) were initially enrolled. All patients were scheduled for a follow-up every 6 months for up to 3 years. EUP was performed to evaluate peri-esophageal collateral veins (peri-ECVs), perforating veins (PFV) and para-esophageal collateral veins (para-ECVs). In addition, computed tomography (CT) were conducted to detect portal vein diameter, portal vein embolus, and major portosystemic collateral shunts. The relationship between esophageal variceal recurrence and EUP findings were analyzed. Results We found that as high as 93.5% of patients developed esophageal variceal recurrence in the 3-year follow-up. The time of esophageal variceal recurrence after variceal eradication was 13.4 months (13.4 ± 9.2 months). Furthermore, the median time of recurrence in patients who were undertaken EVL,EIS and EVL plus EIS was 10, 13 and 12 months, respectively. We identified that the risk factors, including EVL (OR 0.23, 95% CI 0.08–0.71, p < 0.01), Child-Pugh score (OR 3.32,95% CI 1.31–35.35, p < 0.05), large peri-ECVs (OR 4.56, 95% CI 2.17–9.58, p < 0.0001), and existence of PFV (OR 2.14, 95% CI 1.44–3.16, p < 0.001), were significantly associated with the recurrence of esophageal varices. The peri-ECVs and PFV showed better ability to predict esophageal variceal recurrence. When cut-off value of peri-ECVs diameter was 3.5 mm, the specificity of prediction 1-year variceal recurrence was 86% and the sensitivity was 45%. Conclusions The EUP appears to be very effective, convenient and economical examinations to predict esophageal varices recurrence after variceal eradication by endoscopic therapies. The high Child-pugh score, large peri-ECVs, and PFV are independent risk factors related to esophageal varices recurrence.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study

Zheng

Zhang

et al. 2019

BMC Gastroenterol

View full text Add to dashboard Cite

show abstract

“…Further, the use of probing to ascertain the obturation of GVs is a crude method; the use of endoscopic ultrasound (EUS) or endoscopic Doppler would have been a more objective technique. ( 3 )…”

mentioning

confidence: 99%

Letter to the Editor: Is Balloon‐Occluded Retrograde Transvenous Obliteration Superior to Endoscopic Cyanoacrylate in Gastric Varices?

Chinnadurai

Duseja

et al. 2021

Hepatology

Self Cite

View full text Add to dashboard Cite

Endoscopic Doppler Ultrasound Probe: Useful in the Management of Gastric Varices?

Cited by 2 publications

References 10 publications

The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study

The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study

Letter to the Editor: Is Balloon‐Occluded Retrograde Transvenous Obliteration Superior to Endoscopic Cyanoacrylate in Gastric Varices?

Contact Info

Product

Resources

About